Hunton Andrews Kurth Represents Shawkwei & Partners in BSKP Merger Sub, Inc. and ZymeFlow Merger

Hunton Andrews Kurth LLP represented Shawkwei & Partners in connection with the merger of BSKP Merger Sub, Inc. with and into ZymeFlow, a subsidiary of TriStar Group, Inc. As a result, BSKP Merger Sub, Inc. owns one hundred percent of the issued and outstanding capital stock of TriStar Group, Inc. ZymeFlow’s ecofriendly and patented products and services are highly efficient in the decontamination and maintenance of energy and chemical processing facilities in the US and around the world.

ShawKwei & Partners is a private equity industrial investor with offices in Singapore, Hong Kong, San Francisco and Shanghai. After investing, ShawKwei & Partners helps improve a business by partnering with management to identify and realize sustainable performance improvements in sales growth, margin expansion and capital efficiency.

Founded over 35 years ago, ZymeFlow has pioneered innovative chemical decontamination solutions that are more effective, more environmentally friendly and less wasteful than alternatives. ZymeFlow’s diverse line of chemistries are biodegradable and allow clients to meet their sustainability goals, reduce facility downtime and lower costs.

The Hunton Andrews Kurth deal team was led by M&A partners Michael O'Leary and Mark Young and included Corinne Davis and Alexa Williams.